about
Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis.Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.Serological Evidence of Lyssaviruses among Bats on Southwestern Indian Ocean IslandsEvidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptorStructure of the low pH conformation of Chandipura virus G reveals important features in the evolution of the vesiculovirus glycoproteinMolecular and cellular aspects of rhabdovirus entryNovel Approaches to the Prevention and Treatment of RabiesLow-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus.Characterization of intramolecular disulfide bonds and secondary modifications of the glycoprotein from viral hemorrhagic septicemia virus, a fish rhabdovirus.The adaptation of a CTN-1 rabies virus strain to high-titered growth in chick embryo cells for vaccine development.Chimeric lyssavirus glycoproteins with increased immunological potentialAn avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitroEvidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicityGeneration and Characterization of an scFv Directed against Site II of Rabies Glycoprotein.Re-emergence of rabies in the Guangxi province of Southern ChinaQuantifying antigenic relationships among the lyssaviruses.Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.Genetic characterisation of the rabies virus vaccine strains used for oral immunization of foxes in Poland to estimate the effectiveness of vaccinationThe inability of wild-type rabies virus to activate dendritic cells is dependent on the glycoprotein and correlates with its low level of the de novo-synthesized leader RNA.iTRAQ protein profile analysis of neuroblastoma (NA) cells infected with the rabies viruses rHep-Flury and Hep-dG.Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein.Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms.Neutralization-resistant variants of infectious hematopoietic necrosis virus have altered virulence and tissue tropism.Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusionProduction, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans.Reversible conformational changes and fusion activity of rabies virus glycoprotein.Evaluation of rabies biologics against Irkut virus isolated in China.Immunity to fish rhabdovirusesFolding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperonesHost switching in Lyssavirus history from the Chiroptera to the Carnivora orders.Neuronal cell surface molecules mediate specific binding to rabies virus glycoprotein expressed by a recombinant baculovirus on the surfaces of lepidopteran cellsMutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus.SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.
P2860
Q24520604-F1838E0A-5BCA-4538-82EA-2126A604B8ACQ24531953-845D9116-8C3D-46AF-8827-C104D3A339E1Q27331298-7CC8597C-4474-4546-935A-61EDCF3650C6Q27486014-1AEC385B-3632-4ED6-A314-3E949FDBFDDEQ28544977-CD9FF270-324C-46FD-A6B5-FADB7A42BF3AQ28732060-9FEAC57D-08EA-4EA0-B97A-46D74D7580ECQ28818601-3D9E42FA-2DA3-4D7A-8626-474911F7FEA4Q31952001-0ACBC715-48FD-48DC-A3B1-C204115BE635Q31976725-34281E58-702E-403B-B3C9-DBD918B2CFA6Q33620685-690319E9-A437-49E0-8A16-B46748B00F67Q33639069-F222D37D-B4CA-488C-AD18-9DD2AE5D37A6Q33781965-764560E0-4295-4065-A887-8C4A643D63F2Q33838289-4A52B4AC-32BA-4D7E-8B13-3370B680D3C5Q34050438-F17FE448-DAC3-4AE7-8105-073B91518987Q34281714-7B066870-81CD-41FD-A3AD-32CE173AA3E6Q34296085-9AF9370D-8711-42A5-B86F-DD63404C43A3Q34334103-C92824A6-E2D2-459E-9894-662E1AFB0BA0Q35043707-513E5CB9-3FE5-4D8E-8ED3-3792CB8B0BD1Q35115568-1FFA5E72-F1FA-4749-9245-D68A79517454Q35825427-2CC1FE14-5777-40C7-8671-A77A3FFC95FBQ35871495-40B82183-EB71-43E0-9C8D-095D203002C6Q36598941-95E37060-565A-4B3F-82FE-73010D231E9CQ36638373-97226BE0-6FEB-451A-9ACD-5825E70D7BFBQ36643342-C640F2E9-7094-4DF1-A0E8-5283A4081AF0Q36788708-EB41CF04-E2E3-4068-992E-11FB04082118Q36797736-5621489A-CC7A-4CAA-88D0-D93488DCE60CQ37470270-E4A08241-2A24-46DE-BC49-24B76A9E7E61Q37987133-C9EFEE0B-D36A-472E-BD13-4B48616DAFD8Q38346588-FD395A96-7910-4AFC-836F-81435D534E57Q39606804-1043B658-5E70-4F94-9BC5-CF0F858E2DC1Q39642201-4B9C5456-8C67-4F39-B7AB-B67A2B2A00C4Q39685255-23BAB9F3-FCE8-4964-9DF1-A21EE1919246Q39869015-C79EBFAF-95A0-45D0-8E65-2CD13E8E237EQ42680315-D363E940-A2DC-45A7-88C2-E969E8815E52Q47562878-1A75CBCC-2231-4A92-8BF7-2E7365DE9CF6
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Antigenicity of rabies virus glycoprotein
@ast
Antigenicity of rabies virus glycoprotein
@en
Antigenicity of rabies virus glycoprotein
@nl
type
label
Antigenicity of rabies virus glycoprotein
@ast
Antigenicity of rabies virus glycoprotein
@en
Antigenicity of rabies virus glycoprotein
@nl
prefLabel
Antigenicity of rabies virus glycoprotein
@ast
Antigenicity of rabies virus glycoprotein
@en
Antigenicity of rabies virus glycoprotein
@nl
P2093
P2860
P3181
P1433
P1476
Antigenicity of rabies virus glycoprotein
@en
P2093
A Benmansour
C Tuffereau
P2860
P304
P3181
P407
P577
1991-08-01T00:00:00Z